Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.
Recent amendments to a California bill that seeks to place restrictions on the sale of some weight management supplements to minors removed retail access restrictions and clarifies definitions, leading one trade association to remove its objections.
Three trade organizations joined forces in opposing the FDA Safety and Landmark Advancement Act of 2022 (FDASLA), a fee authorization bill that includes provisions aimed at tightening dietary supplement regulations.
Amendments offered by Sen. Mitt Romney, R-UT, could soften some of the hardest edges in an FDA fee reauthorization bill that includes language meant to tighten the regulation of dietary supplements. But the bill still sets a very troubling precedent,...
Weight-loss testimonials "are not adequate substantiation" to prove diets work and specific food references require authorised health claims, the UK Advertising Standards Authority (ASA) has said in a guidance statement.
A bill to restrict some supplement sales has passed the Rhode Island State Senate by an overwhelming vote. The bill remains to be taken up by the state House before the legislature closes shop for the summer on June 30.
The US Food & Drug Administration intends to release multiple draft guidance documents to the industry as smaller, discreet topics relating to New Dietary Ingredients (NDI), a senior figure said recently.
EFSA’s decision this week to stop the clock on 150 CBD (cannabidiol) Novel Food applications and publish a litany of ‘data gaps’ does not threaten thousands of on-market CBD products in the UK, its Food Standards Agency (FSA) has told NutraIngredients.
The European Food Safety Authority (EFSA) has issued a wide-ranging opinion calling for more safety data for CBD products that could challenge the Novel Foods status of many offerings in the nascent category across the bloc and beyond.
The return of the IPA World Congress + Probiota Americas is just one week away. With key scientific insights into one of the industry’s hottest topics, stress management and sleep, register today! Snooze and you lose…
The US Federal Trade Commission is proposing an updated set of rules that would attempt to rein in the burgeoning use of phony reviews to hawk products online. They would also work to prevent the suppression of negative reviews
A mandatory product listing of the sort proposed in a recent bill sponsored by Sen. Dick Durbin, D-IL, would give an illusion of control of the dietary supplement marketplace without better protecting consumers, a prominent industry critic alleges.
A panel of regulatory experts will examine some of the pressing issues in the probiotics filed at the upcoming Probiota Americas event. Questions about New Dietary Ingredients notifications, labeling issues, expanding health indications for probiotics...
FDA announced today that intends to exercise enforcement discretion on missing New Dietary Ingredient Notifications. The Agency also set up a new portal to allow companies to more easily come into compliance by filing the notifications that they should...
The Federal Trade Commission is returning $149 million to consumers who lost money acting as distributors for Advocare, a former multi level marketing company deemed by regulators to have been an illegal pyramid scheme.
FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.
FDA has issued a draft guidance on how to accredit foreign certifying bodies. The document will help clarify a highly technical aspect of the Food Safety and Modernization Act and will remind dietary supplement firms that it’s high time to get their...
China’s food regulator is seeking public consultation on the use of the human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) in infant formula as well as in foods for toddlers and young children.
FDA’s recently announced enforcement discretion policy on NAC will bring some certainty to the market. But it doesn’t answer all of the questions surrounding the ingredient, which could cause other issues later, experts said.
This week, Senators Durbin (D-IL) and Braun (R-IN) introduced S. 4090, the Dietary Supplement Listing Act of 2022, on a bipartisan basis. The legislation would create a mandatory product listing for dietary supplements, similar to the voluntary Supplement...
The Natural Products Association has sent a letter to Senators Dick Durbin and Mike Braun extensively rebutting assertions made in support of their bill that requires mandatory product listing for dietary supplements.
Larisa Pavlick has devoted her entire career to the supplement industry. She spent nearly a decade at FDA focused on consumer safety and also experienced the full product life cycle from the development phase, through purchasing, into manufacturing, brand...
NutraIngredients took the opportunity to speak to Magali Cordaillat-Simmons, Scientific and Regulatory Affairs Director, Pharmabiotic Research Institute (PRI) on regulatory science and how it paves the way for innovative therapies.
The US Food and Drug Administration declared today that it will exercise enforcement discretion on the use of NAC. It also said that it is ‘likely’ to make a rule that would formalize the legal use of the compound in finished dietary supplements.
The Senate candidacy of Dr Mehmet Oz, MD, could pose a public relations risk for the dietary supplement industry, as the prominent media personality gets attacked for being a ‘quack’ who has promoted questionable products.